Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Strategic Business Outlook on the Organ Preservation Solutions Market 2016-2024 - Graying Population and Chronic Diseases Surge Need for Transplants

Research and Markets
Posted on: 04 Jul 18
Strategic Business Outlook on the Organ Preservation Solutions Market 2016-2024 - Graying Population and Chronic Diseases Surge Need for Transplants

PR Newswire

DUBLIN, July 4, 2018

DUBLIN, July 4, 2018 /PRNewswire/ --

The "Organ Preservation Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Organ Preservation Solutions in US$ Thousand.


The report profiles 20 companies including many key and niche players such as:


  • 21st Century Medicine (USA)
  • BioLife Solutions, Inc. (USA)
  • Dr. Franz Khler Chemie GmbH (Germany)
  • Essential Pharmaceuticals, LLC (USA)
  • Lifeline Scientific, Inc. (USA)
  • Preservation Solutions, Inc. (USA)
  • XVIVO Perfusion AB (Sweden)

Key Topics Covered

1. INDUSTRY OVERVIEW
A Prelude
Major Growth Drivers in a Gist
Key Growth Restraints
Current & Future Market Analysis
Geographic Landscape
Competitive Scenario
Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution
XVIVO Sees Brighter Prospects in Organ Preservation Products
Contamination Concerns with Regard to ViaSpan
Organ Preservation Techniques
Simple Cold Storage
Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation

2. MARKET TRENDS AND GROWTH DRIVERS
Growing Awareness and Policy Support on Transplantation to Benefit Market Growth
EVLP: Revolutionary Technique for Lung Preservation
New Paradigms in Heart and Lung Preservation
Organ Banking: Glimpse into the Future?
Preservation Solutions
A Key to Deceased Donor Transplants
Euro-Collins Extending Opportunities in the Kidney Segment
Cardiac Preservation Scenario Remains Static
UW
The Gold Standard in Heart Preservation
Innovative Organ Preservation Solutions on the Horizon
A Focus on Leeds Solutions
Lungs Preservation in Search of Ideal Solution
Scientists See Cryopreservation as a Potential Means for Organ Preservation
UW and HTK Find Growing Use in Abdominal Organ Preservation
UW Vs. HTK in Liver Transplantation
Supercooling Organs
A New Approach to Extend Storage Life
Measures to Address Organ Shortage to Infuse Demand for Preservation Solutions
Machine Perfusion Gains Popularity over Cold Storage
Is Warm Perfusion the Next Standard in Organ Preservation?
Key Organ Transplantation Statistics
Living Donors on the Rise
Graying Population and Chronic Diseases Surge Need for Transplants
Transplant Tourism
Creating Brighter Avenues
Combined Organ Transplantation
Gaining Attention
No. of Transplants by Type (2010-2015)
Cardiac Arrest Death Patients
The Untapped Potential Donors

3. PRODUCT OVERVIEW

4. RECENT INDUSTRY ACTIVITY
BioLife and TissueGene Ink Supply Agreement
BioLife and Promethera Embed CryoStor into HepaStem Manufacturing
BioLife and Bellicum Ink Supply Deal for CryoStor
Cook Embeds BioLife's Media Products into Autologous Cell Therapy
BioLife and Kite Pharma Ink Supply Agreement
Paragonix and Waters Sign Product Supply Agreement
Paragonix Technologies Announces Publication of Sherpa Pak Transport Systems
CFDA Approves Organ Preservation Solutions by Lifeline Scientific
Provepharm Enters Into Partnership with DFKC

5. FOCUS ON SELECT KEY PLAYERS
21st Century Medicine (USA)
BioLife Solutions, Inc. (USA)
Dr. Franz Khler Chemie GmbH (Germany)
Essential Pharmaceuticals, LLC (USA)
Lifeline Scientific, Inc. (USA)
Preservation Solutions, Inc. (USA)
XVIVO Perfusion AB (Sweden)

6. GLOBAL MARKET PERSPECTIVE
 
Total Companies Profiled: 20 (including Divisions/Subsidiaries 22)

  • The United States (12)
  • Europe (8)
    • France (2)
    • Germany (1)
    • The United Kingdom (2)
    • Italy (1)
    • Rest of Europe (2)
  • Asia-Pacific (Excluding Japan) (2)

For more information about this report visit https://www.researchandmarkets.com/research/9z862k/strategic?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



View original content:http://www.prnewswire.com/news-releases/strategic-business-outlook-on-the-organ-preservation-solutions-market-2016-2024---graying-population-and-chronic-diseases-surge-need-for-transplants-300675932.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 04/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.